Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

Medical Digest & Congress Report

Health & Fitness

Episodes

Showing 301-400 of 724
«« ← Prev Page 4 of 8 Next → »»

Next-generation SERD Protects Against Progression in Some Patients With Advanced Breast Cancer Resistant to Standard Hormone Therapy - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Kate Lathrop, MD discusses results from the phase III EMBER-3 clinical trial presented at San Antonio Breast Cancer Symposium 2024. Video: https://med...

Clinical Controversies: Omission of Axillary Staging in ER Positive Breast Cancer: Implications on Adjuvant Therapies - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Monica Morrow, MD, FACS discusses omission of axillary staging in ER positive breast cancer at San Antonio Breast Cancer Symposium 2024. Video: https:...

Risk Reduction and Early Detection: Updates on Breast Cancer Screening - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Ismail Jatoi, MD, PhD, FACS discusses updates on breast cancer screening at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org...

Efficacy and Safety of Trastuzumab Deruxtecan vs Physician’s Choice of Chemotherapy by Pace of Disease Progression on Prior Endocrine-based Therapy - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Prof. Giuseppe Curigliano presents the data of the DESTINY-Breast06 at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scie...

Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Sara A Hurvitz, MD, FACP on the role of endocrine-based therapy in the management of breast cancer at San Antonio Breast Cancer Symposium 2024. Video:...

Immediate Surgery Lowers Local Recurrence in Older Breast Cancer Population - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Prof. Robert Hills presents a comprehensive patient-level meta-analysis of three randomized trials demonstrated that compared with surgery deferral, i...

PARP Inhibition Shows Long-term Survival Benefits for Patients With High-risk, BRCA-positive Breast Cancer in OlympiA Trial - report from SABCS2024

20 Dec 2024

Contributed by Lukas

Judy E. Garber, MD, MPH presents updated results of the OlympiA study at San Antonio Breast Cancer Symposium 2024. The new analysis provides further s...

Daratumumab Shows Better Outcomes Than Active Monitoring for Smoldering Multiple Myeloma - report from ASH2024

20 Dec 2024

Contributed by Lukas

Prof. Meletios-Athanasios Dimopoulos discusses the results of the AQUILA trial, a phase 3 randomized study presented at the 2024 ASH Annual Meeting. N...

Blinatumomab in Combination With Chemotherapy May Improve Survival in Pediatric Patients Newly Diagnosed With B-Cell Precursor ALL - report from ASH2024

20 Dec 2024

Contributed by Lukas

Sumit Gupta, MD, PhD discusses results from the phase 3 Children’s Oncology Group Study AALL1731 presented at the 2024 ASH Annual Meeting. The study...

Guiding Our Patient's Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR-Ts - report from ASH2024

20 Dec 2024

Contributed by Lukas

Gareth Gregory, MBBS, PhD on the options for treatment of diffuse large B-cell lymphoma, which have expanded in recent years, particularly with the em...

High-Fiber NUTRIVENTION Study for Delaying Progression of Myeloma - report from ASH2024

20 Dec 2024

Contributed by Lukas

Urvi A. Shah, MD discusses the NUTRIVENTION study, the current result from the trial, how it may delay progression of myeloma, and the importance of h...

Fixed-Duration Acalabrutinib/Venetoclax in Fit Patients With CLL: AMPLIFY Trial - report from ASH2024

20 Dec 2024

Contributed by Lukas

Jennifer R. Brown, MD, PhD explains the interim analysis of the multicenter, open-label, randomized, phase 3 AMPLIFY trial presented at the 2024 ASH A...

Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis - report from ASH2024

20 Dec 2024

Contributed by Lukas

Suzanne Lentzsch, MD, PhD explains a symposium presented at the 2024 ASH Annual Meeting on the clinical challenges and intricacies of care associated ...

How to improve immunization in children and adolescents? - report from CHEST2024

12 Nov 2024

Contributed by Lukas

Professor Robert Jacobson shares his thoughts on how to improve immunization in children and adolescents. Video: https://medicaldigest.org/scientific-...

New developments in neurendocrine tumours

11 Nov 2024

Contributed by Lukas

Professor Jennifer Chan shares her insights on the new developments in neurendocrine tumours. She talks about studies like CABINET and NETTER-2. Video...

Duchenne Muscular Dystrophy, Then and Now: Lessons from Respiratory Medicine - report from CHEST2024

04 Nov 2024

Contributed by Lukas

David J. Birnkrant, MD, FCCP held the prestigious Margaret Pfrommer Endowed Memorial Lecture In Home-Based Mechanical Ventilation at CHEST 2024. We as...

Update in Vaccines for RSV, COVID, Influenza - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Aanchal Kapoor, MD, FCCP shares her thoughts on updates in RSV, COVID and influenza vaccines. Video: https://medicaldigest.org/scientific-contents/int...

How to manage acute PE? Follow the five D! - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Bhavinkumar Dalal, FACP, MBBS, MD, FCCP chaired a very interesting presentation on controversies for the management of acute pulmonary embolism at CHE...

Breathing Easier: The Evolution and Future of Asthma Care - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Sandhya Khurana, MD, FCCP held the prestigious Mark J. Rosen, MD, Master FCCP Endowed Memorial Lecture at CHEST 2024. We asked her about the lecture a...

Importance of Vaccinations for Patients With Pulmonary Conditions - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Shekhar Ghamande, MBBS, MD, FCCP shares his thoughts on the importance of vaccinations for patients with pulmonary conditions. The important role of t...

Comparison of GINA and EPR-4 Asthma Guidelines - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Shahid Sheikh, MD, FCCP shares his thoughts on the GINA and EPR-4 Asthma Guidelines. Video: https://medicaldigest.org/scientific-contents/interview:co...

New directions in Asthma and COPD - report from CHEST2024

04 Nov 2024

Contributed by Lukas

Monica Kraft, MD, FCCP shares her thoughts on the new directions in Asthma and COPD. Video: https://medicaldigest.org/scientific-contents/interview:ne...

Interplay of Pregnancy and Sleep - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Ghada Bourjeily, MD, FCCP participated in an interesting session about precision medicine for sleep disorders in women, and eplaneined her thoughts on...

Evaluation and Management of VTE in Pregnancy - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Lisa Moores, MD, FCCP shares her thoughts on evaluation and management of VTE in pregnancy. Video: https://medicaldigest.org/scientific-contents/inter...

Beyond Bronchodilators: Bronchoscopic Management of COPD - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Jonathan Kurman, MBA, MD, FCCP shares his thoughts on bronchoscopic management of COPD. Video: https://medicaldigest.org/scientific-contents/intervie...

Portopulmonary Hypertension: How Should We Think About it? - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Hilary Dubrock, MD shares her thoughts on portopulmonary hypertension and explains how we should think about it. Video: https://medicaldigest.org/scie...

Hemodynamic Assessment in Pulmonary Arterial Hypertension - Obtaining the Most Out of Right Heart Catheterization - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Adriano Tonelli, MD shares his thoughts on hemodynamic assessment in pulmonary arterial hypertension. Video: https://medicaldigest.org/scientific-cont...

The role of LABA/LAMA and triple therapy for patients with COPD in GOLD Group E - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Nicola Hanania, MS, MD, FCCP participated in a pro-con debate on the role of LABA/LAMA and triple therapy in patients with COPD. He shared his thought...

CHEST Guidelines on Biologics for Severe Asthma: Evidence, Recommendations, and Clinical Implications - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Megan Conroy, MD, MAEd, FCCP and Amber Oberle, MD share their thoughts about CHEST guidelines on #biologics for severe asthma. Video: https://medicald...

Advanced Management Strategies in Severe Asthma and COPD - report from CHEST2024

01 Nov 2024

Contributed by Lukas

Muhammad Adrish, MBA, MD, FCCP shares his thoughts on personalized treatment strategies for severe asthma and COPD. Video: https://medicaldigest.org/s...

Lymphoma highlights of the ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Maria Gomes da Silva shares his insights on the lymphoma highlights of the ESMO 2024 Congress. She talks about topics like bispecific antibo...

Quadruplet therapy is becoming the new standard of treatment - Multiple myeloma highlights at ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Xavier Leleu shares his insights about the importance of quadruple therapy in multiple myeloma. Video: https://medicaldigest.org/scientific...

Melanoma highlights of the ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Jessica Hassel shares his insights on the melanoma highlights of the ESMO 2024 Congress. She talks about studies like CheckMate067, CheckMat...

Radiation therapy for breast cancer can be safely shortened by changing technique - report from ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Sofia Rivera shares his insights at ESMO 2024 about the phase three HypoG-01 study looking at hypofractionated radiation therapy for breast ...

Prostate Cancer highlights of ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Oliver Sartor shares his insights on the prostate cancer highlights of the ESMO 2024 Congress. Video: https://medicaldigest.org/scientific-c...

Efficacy of 177Lu-PNT2002 in PSMA-Positive mCRPC Following Progression on an Androgen-Receptor Pathway Inhibitor - report from ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Oliver Sartor shares his insights on the SPLASH study. Video: https://medicaldigest.org/scientific-contents/interview:efficacy-177lu-pnt2002...

RCC highlights of ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Camillo Porta shares his insights on the RCC highlights of the ESMO 2024 Congress. He talks about studies like TiNivo-2, CONTACT-03, SUNNIFO...

Breast cancer, metastatic highlights of the ESMO 2024 Congress

24 Oct 2024

Contributed by Lukas

Professor Giampaolo Bianchini shares his insights on the breast cancer metastatic highlights of the ESMO 2024 Congress. Video: https://medicaldigest....

Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in Previously Treated HER2-positive mBC Including a Large Cohort of Patients with Brain Metastases

24 Oct 2024

Contributed by Lukas

Professor Giampaolo Bianchini shares his insights on the DESTINY-Breast12 study. Video: https://medicaldigest.org/scientific-contents/interview:substa...

Randomized Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder Cancer - report from ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Petros Grivas shares his insights on the NIAGARA study. Video: https://medicaldigest.org/scientific-contents/interview:randomized-phase-3-tr...

Adjuvant Pembrolizumab Prolongs DFS Among Patients with High-Risk Muscle Invasive Urothelial Carcinoma - report from ESMO2024

24 Oct 2024

Contributed by Lukas

Professor Petros Grivas shares his insights on the AMBASSADOR study. Video: https://medicaldigest.org/scientific-contents/interview:adjuvant-pembroliz...

Biomarker selected strategies and immunotherapy change the landscape of upper GI tumor treatment - report from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor Yelena Janjigian shares his thoughts on biomarker selected strategies and immunotherapy change the landscape of upper GI tumor treatment fro...

Rise of cancer in young adults - lower GI news from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor Dirk Arnold shares his thoughts on lower gastrointestinal news from ESMO2024. Video: https://medicaldigest.org/scientific-contents/interview...

Eyes to the future: Moving towards molecular and AI-driven oncology - report from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor Federica Di Nicolantonio shares his thoughts on the Rome and GigaPath trials and the importance of moving towards molecular and AI-driven on...

Incorporating novel treatment insights for ER+ early BC patients

11 Oct 2024

Contributed by Lukas

Professor Petra Tesarova shares his thoughts on CDK 4-6 inhibitors in early breast cancer. Video: https://medicaldigest.org/scientific-contents/interv...

Novel targeted therapies for pancreatic cancer - report from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor Davide Melisi shares his thoughts on novel targeted therapies for pancreatic cancer. Video: https://medicaldigest.org/scientific-contents/in...

Systemic therapy for organ preservation - report from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor David Sebag-Montefiore shares his thoughts on systemic therapy for organ preservation and the findings from the NO-CUT trial were presented ...

The Rome Trial From Histology to Target: the Road to Personalize Targeted Therapy and Immunotherapy - report from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor Andrea Botticelli presented the Rome trial results at ESMO 24 Presidential Session. Patients with advanced cancers receiving tumor-agnostic ...

Genitourinary tumours, non-prostate highlights of the ESMO 2024 Congress

11 Oct 2024

Contributed by Lukas

Professor Aristotelis Bamias shares his thoughts on genitourinary tumours highlights of the ESMO 2024 Congress. Video: https://medicaldigest.org/scien...

Lung cancer interception: New approaches to lung cancer screening and prevention - report from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor Jianjun Zhang shares his thoughts on lung cancer screening and prevention. Video: https://medicaldigest.org/scientific-contents/interview:lu...

Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: Overall survival results from the randomized, double-blind, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study

11 Oct 2024

Contributed by Lukas

Professor Domenica Lorusso presented the overall survival results from the randomized, double-blind, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study. Pe...

LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib + Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma - report from ESMO2024

11 Oct 2024

Contributed by Lukas

Professor Josep Llovet discusses the results of LEAP-012 Study which he presented at ESMO 2024. Video: https://medicaldigest.org/scientific-contents/i...

Adding Metformin to ADT for Patients with mHSPC: Overall Survival Results from the Multi-Arm, Multi-Stage Randomized Platform Trial STAMPEDE - report from ESMO2024

28 Sep 2024

Contributed by Lukas

Professor Silke Gillessen discussing results from STAMPEDE trial assessing the addition of metformin to ADT for patients with mHSPC. Video: https://me...

PEACE-3 Trial Shows Combination Therapy Improves Survival in Prostate Cancer - report from ESMO2024

28 Sep 2024

Contributed by Lukas

Professor Silke Gillessen presented new results from the PEACE-3 trial at the 2024 ESMO conference. This study indicates that combining Enzalutamide w...

Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC: Overall survival results from the phase 3 KEYNOTE-522 study

28 Sep 2024

Contributed by Lukas

Professor Peter Schmid presented the overall survival results from the phase 3 KEYNOTE-522 study at ESMO 2024 Congress. Neoadjuvant pembrolizumab or p...

POD1UM-303/InterAACT 2: Potentially Practice-Changing Findings in SCAC - report from ESMO2024

28 Sep 2024

Contributed by Lukas

Professor Dominik P. Modest shares his thoughts on POD1UM-303/InterAACT 2 study, which are potentially practice-changing findings in squamous cell car...

Setting a new benchmark for ALK+ aNSCLC targeted therapy - report from ESMO2024

28 Sep 2024

Contributed by Lukas

Professor Tony S.K. Mok shares his thoughts on setting a new benchmark for ALK+ aNSCLC targeted therapy. Video: https://medicaldigest.org/scientific-c...

Breast cancer, early stage highlights of the ESMO 2024 Congress

28 Sep 2024

Contributed by Lukas

Professor Ann Partridge shares his thoughts on breast cancer, early stage highlights of the ESMO 2024 Congress. Video: https://medicaldigest.org/scien...

Adjuvant Pembrolizumab/Chemotherapy Misses DFS End Point in High-Risk Endometrial Cancer, but Benefits dMMR Subgroup - report from ESMO2024

28 Sep 2024

Contributed by Lukas

Professor Remi Nout shares his thoughts on the interim results of the phase 3 ENGOT-en11/GOG-3053/KEYNOTE-B21 trial that were presented during the ESM...

Treatment of cervical cancer in 2024 in the highlight of KEYNOTE-A18 study - report from ESMO2024

28 Sep 2024

Contributed by Lukas

Professor Remi Nout shares his thoughts on the treatment of cervical cancer in 2024 in the light of KEYNOTE-A18 study. Video: https://medicaldigest.or...

New pillars of optimal medical treatment in heart failure - report from ESC2024

25 Sep 2024

Contributed by Lukas

Prof. Michael Böhm explains how SGLT-2 inhibitors became a strong pillar of treatment in HFrEF and HFpEF patients. Their antidiabetic effect and kidn...

Highlihts of ERS 2024 - The President's perspective

20 Sep 2024

Contributed by Lukas

Prof. Carlos Robalo Cordeiro, immediate Past-President of the ERS shares his thoughts on the highlights of ERS 2024. Video: https://medicaldigest.org/...

Why is idiopathic pulmonary fibrosis not so idiopathic? - report from ERS2024

20 Sep 2024

Contributed by Lukas

Prof. Michael Kreuter co-chaired a very interesting session at this years ERS congress on novelties in the treatement of interstitial lung diseases an...

Improving Lung Health in the 21st century - report from ERS2024

20 Sep 2024

Contributed by Lukas

Prof. Joan B. Soriano co-chaired a very interesting session at this years ERS congress on the challenges of increasing urbanisation for respiratory he...

Overcoming the challenges of increasing urbanisation for respiratory health - report from ERS2024

19 Sep 2024

Contributed by Lukas

Prof. Ane Johannessen co-chaired an interesting session to identify how future city life around the world may have the potential to improve respirator...

Thoracic oncology - Lung cancer diagnostics and treatment challenges - report from ERS2024

19 Sep 2024

Contributed by Lukas

Prof. Maria Joana Pereira Catarata co-chaired a very interesting session on lung cancer diagnostics and treatment challenges. Video: https://medicaldi...

Novel research data on asthma and chronic obstructive pulmonary disease management: clinical applications - report from ERS2024

19 Sep 2024

Contributed by Lukas

Prof. Charlotte Suppli Ulrik co-chaired a very interesting session at this years ERS congress on novel research data on asthma and chronic obstructive...

COPD in a nutshell at ERS2024

18 Sep 2024

Contributed by Lukas

Prof. Nick Hopkinson shares his thoughts on the challenges and management of COPD. Video: https://medicaldigest.org/scientific-contents/interview:copd...

Paediatric asthma in 2024: from prevention to transition - report from ERS2024

18 Sep 2024

Contributed by Lukas

Prof. Andrew Bush co-chaired a very interesting session on the prevention and treatment of paediatric asthma. Video: https://medicaldigest.org/scienti...

How to change urban areas to improve the life of allergic patients? - report from ERS2024

18 Sep 2024

Contributed by Lukas

Dr. Alessandro Marcon on how to change urban areas to improve the life of allergic patients? Video: https://medicaldigest.org/scientific-contents/inte...

Paediatric asthma in 2024: from prevention to transition - report from ERS2024

18 Sep 2024

Contributed by Lukas

Prof. Angela Zacharasiewicz shares her thoughts on the prevention and treatment of paediatric asthma. To find out more, visit the Children's Bronc...

Smoke-free Europe: utopia or feasible reality? - report from ERS2024

18 Sep 2024

Contributed by Lukas

Prof. Nick Hopkinson on the goal of a smoke-free generation. Video: https://medicaldigest.org/scientific-contents/interview:smoke-free-europe-utopia-o...

Respiratory Medicine against Lung Cancer - report from ERS2024

18 Sep 2024

Contributed by Lukas

Prof. Joanna Chorostowska-Wynimko, President Elect of the European Respiratory Society gave us a brief summary on the state-of-the-art respiratory med...

What is the benefit of starting earlier PCSK9 inhibitors for acute coronary syndromes? - report from ESC2024

18 Sep 2024

Contributed by Lukas

Professor Marc Bonaca explains what is the benefit of starting earlier PCSK9 inhibitors for acute coronary syndromes? Video: https://medicaldigest.org...

Pre-diabetes: a risk factor for cardiovascular disease? - report from ESC2024

18 Sep 2024

Contributed by Lukas

Professor Antonio Ceriello co-chaired a very interesting session on prediabetes. He shared his thoughts on the field with us. Video: https://medicaldi...

Patient engagement in lipid-lowering therapies - report from ESC2024

17 Sep 2024

Contributed by Lukas

Professor Vera Bittner shares her experiences in patient engagement in lipid-lowering therapies. Video: https://medicaldigest.org/scientific-contents/...

Guidelines in Practice: implementing the 2023 Focused Update on Heart Failure - target, treat, and titrate - report from ESC2024

17 Sep 2024

Contributed by Lukas

Professor Piotr Ponikowski shares his experiences on ESC Clinical Practice Guidelines in implementing the 2023 Focused Update on Heart Failure. Video:...

Cardiovascular multimorbid patients’ care - report from ESC2024

17 Sep 2024

Contributed by Lukas

Professor Claudio Borghi shares his insights on cardiovascular multimorbid patients’ care. Video: https://medicaldigest.org/scientific-contents/inte...

2024 ESC Guidelines for the Management of Atrial Fibrillation - report from ESC2024

17 Sep 2024

Contributed by Lukas

Professor Isabelle C. Van Gelder co-chaired the guideline task force on the 2024 ESC Guidelines for the Management of Atrial Fibrillation. Video: http...

2024 ESC Guidelines for the Management of Chronic Coronary Syndromes - report from ESC2024

17 Sep 2024

Contributed by Lukas

Professor Christiaan Vrints co-chaired the guideline task force on the 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes. Video: ht...

EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease - report from ESC2024

16 Sep 2024

Contributed by Lukas

Professor Gi-Byoung Nam explains thtat edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agen...

FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials - report from ESC2024

16 Sep 2024

Contributed by Lukas

Professor Muthiah Vaduganathan explains that the FINE-HEART pooled analysis of three large trials failed to demonstrate significant reductions in card...

Chronic ischaemic syndrome management in 2024: are we ready for the (r)evolution? - report from ESC2024

16 Sep 2024

Contributed by Lukas

Professor Mario Marzilli highlights the evolving environment of chronic coronary syndrome management and translates new ESC chronic coronary syndrome ...

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis - report from ESC2024

13 Sep 2024

Contributed by Lukas

Professor Pardeep Jhund explains that mineralocorticoid receptor antagonists reduced the risk of cardiovascular death or heart failure hospitalization...

Guidelines in Practice: cardio-renal protection in patients with diabetes - report from ESC2024

12 Sep 2024

Contributed by Lukas

Professor Ramzi Ajjan shares his insights on cardio-renal protection in patients with diabetes. Video: https://medicaldigest.org/scientific-contents/i...

2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases - report from ESC2024

12 Sep 2024

Contributed by Lukas

Professor José Rodriguez Palomares co-chaired the guideline task force on 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Di...

The Dundee experience: really personalised acute stroke treatment! - report from ESC2024

12 Sep 2024

Contributed by Lukas

Professor Iris Grunwald shares her experience of personalised stroke management. Video: https://medicaldigest.org/scientific-contents/interview:dundee...

Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control - report from ESC2024

12 Sep 2024

Contributed by Lukas

Professor Johanne Silvain presented results of the ABYSS trial in a Hot Line session at ESC Congress 2024. The cardiovascular safety of interrupting b...

ESC Clinical Practice Guidelines 2022 and 2023 for General Practice and General Cardiology: where do we stand? - report from ESC2024

12 Sep 2024

Contributed by Lukas

Professor Konstantinos Toutouzas co-chaired an interresting session for general clinicians the ESC Guidelines on Cardio-Oncology and Management of Car...

Patient with diabetes, heart failure with reduced ejection fraction, and impaired kidney function: how to implement the guidelines and take-home messages - report from ESC2024

11 Sep 2024

Contributed by Lukas

Professor Nikolaus Marx shares his insights on patient with diabetes, heart failure with reduced ejection fraction, and impaired kidney function. How ...

Clash of the titans: when cardiovascular and kidney diseases overlap - report from ESC2024

10 Sep 2024

Contributed by Lukas

Professor Roser Torra shares his insigths od o ESC joint session with the European Renal Association as well as the four foundational therapies availa...

Chronic coronary syndrome: the journey so far and the road to the future - report from ESC2024

10 Sep 2024

Contributed by Lukas

Professor Athanasios John Manolis provides an overview of current guidelines recommendations and the importance of an individualized patient-centered ...

Clinical trial updates on the GLP-1 receptor agonists - report from ESC2024

10 Sep 2024

Contributed by Lukas

Professor Mikhail Kosiborod provides a summary of the clinical trial updates on the GLP-1 receptor agonists. Video: ⁠https://medicaldigest.org/scien...

QUADRO - A single 4-drug combination in hypertension - report from ESC2024

10 Sep 2024

Contributed by Lukas

Principal Investigator, Professor Stefano Taddei explaining why new treatment strategies are needed for hypertension. He presented in a Hot Line sessi...

The importance of the anterior interface in eye surgery

24 Jul 2024

Contributed by Lukas

Professor Marie-José Tassignon shares her insight on pediatric cataract surgery, she speaks about the importance of anatomical changes in the anterio...

How to treat atherosclerosis? - Highlights of the EAS 2024 (Part II)

16 Jul 2024

Contributed by Lukas

Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis. The second part of our two-part int...

How to treat atherosclerosis? - Highlights of the EAS 2024 (Part I)

16 Jul 2024

Contributed by Lukas

Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis. The first part of our two-part inte...

75th Anniversary of Glucocorticoids - what have we learnt? - report from EULAR2024

10 Jul 2024

Contributed by Lukas

Sytske Anne Bergstra at the recent EULAR 2024 chaired a session on the use of glucocorticoids in the therapy of rheumatoid arthritis. What were the ke...

Early and maintained comparative effectiveness of 5 different classes of advanced therapies in a large multinational cohort of real-world PsA patients - report from EULAR2024

21 Jun 2024

Contributed by Lukas

Professor Dennis McGonagle explains the results of an EULAR 2024 late breaking abstract, the PRO-SPIRIT study, early (3-month) and maintained (12-mont...

Effectiveness of Canakinumab for first line steroid free treatment in systemic juvenile idiopathic arthritis - report from EULAR2024

21 Jun 2024

Contributed by Lukas

Professor Gerd Horneff explains the results of a late breaking abstract from EULAR 2024, effectiveness of canakinumab for first line steroid free trea...

«« ← Prev Page 4 of 8 Next → »»